ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - BIT:1LLY - US5324571083 - Common Stock
885 EUR
+1.4 (+0.16%)
1LLY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. 1LLY scores excellent on profitability, but there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth. These ratings would make 1LLY suitable for growth investing!
1. Profitability
1.1 Basic Checks
1LLY had positive earnings in the past year.
In the past year 1LLY had a positive cash flow from operations.
In the past 5 years 1LLY has always been profitable.
Each year in the past 5 years 1LLY had a positive operating cash flow.
1.2 Ratios
1LLY's Return On Assets of 16.02% is amongst the best of the industry. 1LLY outperforms 92.59% of its industry peers.
With an excellent Return On Equity value of 77.38%, 1LLY belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
1LLY has a Return On Invested Capital of 28.84%. This is amongst the best in the industry. 1LLY outperforms 96.30% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1LLY is significantly above the industry average of 14.51%.
The last Return On Invested Capital (28.84%) for 1LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
With an excellent Profit Margin value of 30.99%, 1LLY belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
In the last couple of years the Profit Margin of 1LLY has declined.
The Operating Margin of 1LLY (44.41%) is better than 98.15% of its industry peers.
In the last couple of years the Operating Margin of 1LLY has grown nicely.
With an excellent Gross Margin value of 83.03%, 1LLY belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1LLY is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
Compared to 5 years ago, 1LLY has less shares outstanding
The debt/assets ratio for 1LLY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.20 indicates that 1LLY is not in any danger for bankruptcy at the moment.
1LLY's Altman-Z score of 8.20 is amongst the best of the industry. 1LLY outperforms 96.30% of its industry peers.
1LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as 1LLY would need 6.60 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.60, 1LLY is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
1LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
1LLY has a Debt to Equity ratio of 1.72. This is in the lower half of the industry: 1LLY underperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.2 |
ROIC/WACC3.31
WACC8.72%
2.3 Liquidity
A Current Ratio of 1.55 indicates that 1LLY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, 1LLY is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
1LLY has a Quick Ratio of 1.24. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
1LLY has a better Quick ratio (1.24) than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
1LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.22%, which is quite impressive.
The Earnings Per Share has been growing by 16.57% on average over the past years. This is quite good.
The Revenue has grown by 45.41% in the past year. This is a very strong growth!
1LLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.08% yearly.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
1LLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.75% yearly.
1LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.43% yearly.
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 46.88 indicates a quite expensive valuation of 1LLY.
Compared to the rest of the industry, the Price/Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 61.11% of the companies listed in the same industry.
1LLY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.89.
With a Price/Forward Earnings ratio of 33.16, 1LLY can be considered very expensive at the moment.
64.81% of the companies in the same industry are cheaper than 1LLY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.59. 1LLY is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.88 | ||
| Fwd PE | 33.16 |
4.2 Price Multiples
1LLY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1LLY is more expensive than 70.37% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1LLY is valued a bit more expensive than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 151.58 | ||
| EV/EBITDA | 35.64 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1LLY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 42.29% in the coming years.
PEG (NY)0.58
PEG (5Y)2.83
EPS Next 2Y54.64%
EPS Next 3Y42.29%
5. Dividend
5.1 Amount
With a yearly dividend of 0.59%, 1LLY is not a good candidate for dividend investing.
1LLY's Dividend Yield is comparable with the industry average which is at 3.01.
With a Dividend Yield of 0.59, 1LLY pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
5.2 History
The dividend of 1LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
28.28% of the earnings are spent on dividend by 1LLY. This is a low number and sustainable payout ratio.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.28%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
BIT:1LLY (11/14/2025, 7:00:00 PM)
885
+1.4 (+0.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap837.62B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80
Price Target787.88 (-10.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
Yearly Dividend4.24
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)2.56%
PT rev (3m)-6.7%
EPS NQ rev (1m)2.11%
EPS NQ rev (3m)2.55%
EPS NY rev (1m)2.48%
EPS NY rev (3m)7.64%
Revenue NQ rev (1m)1.94%
Revenue NQ rev (3m)2.48%
Revenue NY rev (1m)1.37%
Revenue NY rev (3m)4.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.88 | ||
| Fwd PE | 33.16 | ||
| P/S | 16.42 | ||
| P/FCF | 151.58 | ||
| P/OCF | 60.74 | ||
| P/B | 41.01 | ||
| P/tB | 85.22 | ||
| EV/EBITDA | 35.64 |
EPS(TTM)18.88
EY2.13%
EPS(NY)26.69
Fwd EY3.02%
FCF(TTM)5.84
FCFY0.66%
OCF(TTM)14.57
OCFY1.65%
SpS53.9
BVpS21.58
TBVpS10.38
PEG (NY)0.58
PEG (5Y)2.83
Graham Number95.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.2 |
F-Score7
WACC8.72%
ROIC/WACC3.31
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y30.03%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / 1LLY.MI FAQ
What is the fundamental rating for 1LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
Can you provide the valuation status for ELI LILLY & CO?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
Can you provide the profitability details for ELI LILLY & CO?
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for 1LLY stock?
The Price/Earnings (PE) ratio for ELI LILLY & CO (1LLY.MI) is 46.88 and the Price/Book (PB) ratio is 41.01.
How financially healthy is ELI LILLY & CO?
The financial health rating of ELI LILLY & CO (1LLY.MI) is 5 / 10.